Meeting of the National Advisory Council for Healthcare Research and Quality, 10091-10092 [2021-03182]
Download as PDF
<![CDATA[
10091
Federal Register / Vol. 86, No. 31 / Thursday, February 18, 2021 / Notices
to the purpose of the visit and provide
a verbal refusal of entry.
FDA estimates the burden of this
collection of information as follows:
TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
Activity
2023–2024 Data Collection (Healthcare Facilities)—Completion of Sections 1 and 3.
2023–2024 Data Collection (Schools)—Completion of Sections 1 and 3.
2023–2024 Data Collection (Retail Food Stores)—
Completion of Sections 1 and 3.
2023–2024 Data Collection-Completion of Section
2—All Facility Types.
2023–2024 Data Collection-Entry Refusals—All
Facility Types.
Number of
non-respondents
Number of
responses per
non-respondent
Total annual
non-responses
Average burden
per response
Total
hours
400
1
400
............................
..........................
..........................
2.5 ..........................
1,000
400
1
400
............................
..........................
..........................
2 .............................
800
400
1
400
............................
..........................
..........................
3 .............................
1,200
1
1,200
............................
..........................
..........................
0.5 (30 minutes) .....
600
......................
..........................
......................
24
1
24
0.08 (5 minutes) .....
1.92
3,601.92
..........................
......................
............................
..........................
..........................
................................
................
are no capital costs or operating and maintenance costs associated with this collection of information.
Based on a review of the information
collection since our last request for
OMB approval, we have made no
adjustments to our burden estimate.
II. References
The following references are on
display in the Dockets Management
Staff (see ADDRESSES) and are available
for viewing by interested persons
between 9 a.m. and 4 p.m., Monday
through Friday; they are also available
electronically at https://
www.regulations.gov. FDA has verified
the website addresses, as of the date this
document publishes in the Federal
Register, but websites are subject to
change over time.
jbell on DSKJLSW7X2PROD with NOTICES
Total annual
responses
1,200
Total .................................................................
1 There
Number of
responses per
respondent
1. ‘‘Report of the FDA Retail Food Program
Database of Foodborne Illness Risk
Factors (2000).’’ Available at: https://
wayback.archive-it.org/7993/
20170406023019/https://www.fda.gov/
downloads/Food/GuidanceRegulation/
UCM123546.pdf.
2. ‘‘FDA Report on the Occurrence of
Foodborne Illness Risk Factors in
Selected Institutional Foodservice,
Restaurant, and Retail Food Store
Facility Types (2004).’’ Available at:
https://wayback.archive-it.org/7993/
20170406023011/https://www.fda.gov/
downloads/Food/GuidanceRegulation/
RetailFoodProtection/
FoodborneIllnessRiskFactorReduction/
UCM423850.pdf.
3. ‘‘FDA Report on the Occurrence of
Foodborne Illness Risk Factors in
Selected Institutional Foodservice,
Restaurant, and Retail Food Store
Facility Types (2009).’’ Available at:
https://wayback.archive-it.org/7993/
20170406023004/https://www.fda.gov/
Food/GuidanceRegulation/
RetailFoodProtection/
FoodborneIllnessRiskFactorReduction/
ucm224321.htm.
4. FDA National Retail Food Team. ‘‘FDA
Trend Analysis Report on the
Occurrence of Foodborne Illness Risk
Factors in Selected Institutional
Foodservice, Restaurant, and Retail Food
Store Facility Types (1998–2008).’’
(2010). Available at: https://
VerDate Sep<11>2014
17:47 Feb 17, 2021
Jkt 253001
wayback.archive-it.org/7993/
20170406022950/https://www.fda.gov/
Food/GuidanceRegulation/
RetailFoodProtection/
FoodborneIllnessRiskFactorReduction/
ucm223293.htm.
5. ‘‘FDA Food Code.’’ Available at: https://
www.fda.gov/food/retail-food-protection/
fda-food-code.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: February 11, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for
Policy.
AGENCY:
[FR Doc. 2021–03248 Filed 2–17–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute on
Aging Special Emphasis Panel, March
15, 2021, 10:00 a.m. to March 15, 2021,
07:00 p.m., National Institute on Aging,
Gateway Building, 7201 Wisconsin
Avenue, Bethesda, MD 20892, which
was published in the Federal Register
on February 04, 2021, 86 FR 8215.
The meeting notice is amended to
change the date of the meeting from
March 1, 2021 to March 15, 2021. The
meeting is closed to the public.
Dated: February 12, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–03255 Filed 2–17–21; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Agency for Healthcare Research and
Quality
Meeting of the National Advisory
Council for Healthcare Research and
Quality
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
This notice announces a
meeting of the National Advisory
Council for Healthcare Research and
Quality.
SUMMARY:
The meeting will be held on
Thursday, March 18, 2021, from 10:00
a.m. to 2:00 p.m.
ADDRESSES: The meeting will be held
virtually.
DATES:
FOR FURTHER INFORMATION CONTACT:
Jaime Zimmerman, Designated
Management Official, at the Agency for
Healthcare Research and Quality, 5600
Fishers Lane, Mail Stop 06E37A,
Rockville, Maryland, 857, (301) 427–
1456. For press-related information,
please contact Bruce Seeman at (301)
427–1998 or Bruce.Seeman@
AHRQ.hhs.gov.
Closed captioning will be provided
during the meeting. If another
reasonable accommodation for a
disability is needed, please contact the
Food and Drug Administration (FDA)
Office of Equal Employment
Opportunity and Diversity Management
on (301) 827–4840, no later than
Monday, March 1, 2021. The agenda,
roster, and minutes will be available
from Ms. Heather Phelps, Committee
Management Officer, Agency for
Healthcare Research and Quality, 5600
Fishers Lane, Rockville, Maryland,
20857. Ms. Phelps’ phone number is
(301) 427–1128.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\18FEN1.SGM
18FEN1
10092
Federal Register / Vol. 86, No. 31 / Thursday, February 18, 2021 / Notices
I. Purpose
In accordance with section 10(a) of
the Federal Advisory Committee Act, 5
U.S.C. App., this notice announces a
meeting of the National Advisory
Council for Healthcare Research and
Quality (the Council). The Council is
authorized by Section 941 of the Public
Health Service Act, 42 U.S.C. 299c. In
accordance with its statutory mandate,
the Council is to advise the Secretary of
the Department of Health and Human
Services and the Director of AHRQ on
matters related to AHRQ’s conduct of its
mission including providing guidance
on (A) priorities for health care research,
(B) the field of health care research
including training needs and
information dissemination on health
care quality and (C) the role of the
Agency in light of private sector activity
and opportunities for public private
partnerships. The Council is composed
of members of the public, appointed by
the Secretary, and Federal ex-officio
members specified in the authorizing
legislation.
II. Agenda
On Thursday, March 18, 2021, the
Council meeting will convene at 10:00
a.m., with the call to order by the
Council Chair and approval of previous
Council summary notes. The meeting
will begin with an update on AHRQ’s
recent accomplishments in Health
Systems Research, Practice
Improvement, Data and Analytics, and
achieving organizational excellence.
The agenda will also include a
discussion of communication and value
of health systems research, an update on
PCOR Trust Funds, and a discussion of
how AHRQ may advance health equity.
The meeting will adjourn at 2:00 p.m.
The meeting is open to the public. For
information regarding how to access the
meeting as well as other meeting details,
including information on how to make
a public comment, please go to https://
www.ahrq.gov/news/events/nac/. The
final agenda will be available on the
AHRQ website no later than Thursday,
March 11, 2021.
jbell on DSKJLSW7X2PROD with NOTICES
Dated: February 11, 2021.
Marquita Cullom,
Associate Director.
[FR Doc. 2021–03182 Filed 2–17–21; 8:45 am]
BILLING CODE 4160–90–P
VerDate Sep<11>2014
17:47 Feb 17, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Institutes of Health
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—Funding
Opportunity Announcement (FOA),
PAR 20–280, Cooperative Research
Agreements to the World Trade Center
Health Program (U01); and RFA OH–
21–004, Exploratory/Developmental
Grants Related to the World Trade
Center Health Program (R21);
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP)—Funding
Opportunity Announcement (FOA),
PAR 20–280, Cooperative Research
Agreements to the World Trade Center
Health Program (U01); and RFA OH–21–
004, Exploratory/Developmental Grants
Related to the World Trade Center
Health Program (R21), March 16–17,
2021, from 9:00 a.m.–6:00 p.m., EDT;
and March 18, 2021, from 9:00 a.m.–
12:00 p.m., EDT, in the original FRN.
The virtual meeting was published in
the Federal Register on Monday,
January 11, 2021, Volume 86, Number 6,
pages 1975–1976.
The virtual meeting is being amended
to change the dates and times and
should read as follows:
Dates and Times: March 16–17, 2021,
from 1:00 p.m.–5:00 p.m., EDT.
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT:
Marilyn Ridenour B.S.N., M.B.A.,
M.P.H., C.P.H., C.I.C., CAPT, USPHS,
Scientific Review Officer, CDC, National
Institute for Occupational Safety and
Health, 1095 Willowdale Road, Mailstop
1811, Morgantown, West Virginia
26505, Telephone (304) 285–5879.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA
R13 Conference Grant Review.
Date: April 1, 2021.
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Preethy Nayar, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Drug Abuse,
NIH, 301 North Stonestreet Avenue, MSC
6021 Bethesda, MD 20892, 301–443–4577
nayarp2@csr.nih.gov
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: February 11, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–03187 Filed 2–17–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Prospective Grant of an Exclusive
Patent License: Allogeneic Therapy for
the Treatment of Autoimmune Disease
Using Chimeric Antigen Receptors
Targeting CD19
[FR Doc. 2021–03230 Filed 2–17–21; 8:45 am]
AGENCY:
BILLING CODE 4163–18–P
HHS.
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
E:\FR\FM\18FEN1.SGM
National Institutes of Health,
18FEN1
]]>Agencies
[Federal Register Volume 86, Number 31 (Thursday, February 18, 2021)]
[Notices]
[Pages 10091-10092]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03182]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Meeting of the National Advisory Council for Healthcare Research
and Quality
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces a meeting of the National Advisory
Council for Healthcare Research and Quality.
DATES: The meeting will be held on Thursday, March 18, 2021, from 10:00
a.m. to 2:00 p.m.
ADDRESSES: The meeting will be held virtually.
FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management
Official, at the Agency for Healthcare Research and Quality, 5600
Fishers Lane, Mail Stop 06E37A, Rockville, Maryland, 857, (301) 427-
1456. For press-related information, please contact Bruce Seeman at
(301) 427-1998 or [email protected].
Closed captioning will be provided during the meeting. If another
reasonable accommodation for a disability is needed, please contact the
Food and Drug Administration (FDA) Office of Equal Employment
Opportunity and Diversity Management on (301) 827-4840, no later than
Monday, March 1, 2021. The agenda, roster, and minutes will be
available from Ms. Heather Phelps, Committee Management Officer, Agency
for Healthcare Research and Quality, 5600 Fishers Lane, Rockville,
Maryland, 20857. Ms. Phelps' phone number is (301) 427-1128.
SUPPLEMENTARY INFORMATION:
[[Page 10092]]
I. Purpose
In accordance with section 10(a) of the Federal Advisory Committee
Act, 5 U.S.C. App., this notice announces a meeting of the National
Advisory Council for Healthcare Research and Quality (the Council). The
Council is authorized by Section 941 of the Public Health Service Act,
42 U.S.C. 299c. In accordance with its statutory mandate, the Council
is to advise the Secretary of the Department of Health and Human
Services and the Director of AHRQ on matters related to AHRQ's conduct
of its mission including providing guidance on (A) priorities for
health care research, (B) the field of health care research including
training needs and information dissemination on health care quality and
(C) the role of the Agency in light of private sector activity and
opportunities for public private partnerships. The Council is composed
of members of the public, appointed by the Secretary, and Federal ex-
officio members specified in the authorizing legislation.
II. Agenda
On Thursday, March 18, 2021, the Council meeting will convene at
10:00 a.m., with the call to order by the Council Chair and approval of
previous Council summary notes. The meeting will begin with an update
on AHRQ's recent accomplishments in Health Systems Research, Practice
Improvement, Data and Analytics, and achieving organizational
excellence. The agenda will also include a discussion of communication
and value of health systems research, an update on PCOR Trust Funds,
and a discussion of how AHRQ may advance health equity. The meeting
will adjourn at 2:00 p.m. The meeting is open to the public. For
information regarding how to access the meeting as well as other
meeting details, including information on how to make a public comment,
please go to https://www.ahrq.gov/news/events/nac/. The final agenda
will be available on the AHRQ website no later than Thursday, March 11,
2021.
Dated: February 11, 2021.
Marquita Cullom,
Associate Director.
[FR Doc. 2021-03182 Filed 2-17-21; 8:45 am]
BILLING CODE 4160-90-P
